Lilly Rebuffed by Supreme Court on $194 Million Medicaid Award

The US Supreme Court let stand a $194 million award against Eli Lilly & Co. in a whistleblower suit accusing the company of engaging in Medicaid fraud by misreporting its drug prices.

The justice without comment refused to consider a far-reaching company appeal that sought to overturn the US False Claims Act. Lilly contended that the law violates the Constitution by authorizing private parties to enforce federal law on behalf of the government and then share any recovery.